Certified by Founder Lodge
Syncona Limited
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $28,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science.
Our vision is to build a sustainable, diverse por
| Company | Date | Round | Raised |
|---|---|---|---|
 Mosaic TX |
April, 05 ,2023 | Series A | $28,000,000 |
 Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
 Resolution Therapeutics |
October, 03 ,2024 | Unknown | $83,383,437 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
